Barbigerone Potentially Alleviates Rotenone-Activated Parkinson's Disease in a Rodent Model by Reducing Oxidative Stress and Neuroinflammatory Cytokines.
Khalid M AlharthyHassan N AlthurwiFaisal F AlbaqamiAli I AltharawiSami I AlzareaFahad A Al-AbbasiMuhammad Shahid NadeemImran KazmiPublished in: ACS omega (2023)
The results demonstrated that barbigerone exhibits antioxidant and anti-inflammatory actions via reducing oxidative stress and inflammatory cytokines. Altogether, these findings suggest that barbigerone could potentially be utilized as a therapeutic agent against PD.